Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80

Deals > All

Find below a list of collaborations and financings!

Total search results: 715 | Ordered by Date (descending)
1 2 3 4 5 6 7 8  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
QInstruments–Bico: investment, 202110– acquisition 100% cash/debt free for €58.25m upfront + €3m milestones thereof 13% paid in new Bico shares 2021-10-01
Thermo Fisher–Carbon Engineering: analytical technology, 202109 collab existent direct air capture technology to reduce CO2 emissions 2021-09-23
Hurel–Bico: investment, 202109 acquisition $2.5m of assets + operations of Hurel Corp + integration in Visikol 2021-09-15
Agena Bioscience–Mesa Labs: investment, 202109– acquisition $300m in cash of Agena by Mesa Laboratories ANNOUNCED 2021-09-14
Evotec–Biognosys: MS-based proteomics, 202109– collab integration of Spectronaut proteomics data analys into drug discovery + clinical proteomics 2021-09-14
Owlstone–Horizons Ventures: investment, 202109 financing round Series D totalling $58m incl existing + lead investor Horizons Ventures 2021-09-07
Owlstone–SEVERAL: investment, 202109 financing round Series D $58m of Owlstone Medical led by existing investor Horizons Ventures 2021-09-07
Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology 2021-08-27
Spectricity–SEVERAL: investment, 202108 financing round Series B €14m 2021-08-03
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED 2021-07-26
Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds 2021-07-21
Mobilion–SEVERAL: investment, 202107 financing round Series C $60m led by new investor D1 Capital Partners 2021-07-13
Discover Echo–Cellink: investment, 202106– acquisition $110m with $98m in cash + $12m in new Series B shares ANNOUNCED 2021-06-26
Paramit–Tecan: investment, 202106– acquisition $1b from Altaris Capital Partners LLC ANNOUNCED 2021-06-23
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool 2021-06-22
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS 2021-06-22
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED 2021-06-22
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED 2021-06-17
Chemic Laboratories–Solvias: investment, 202106 acquisition €na by Solvias 2021-06-17
IonSense–Covalent Bonds: public relations, 202106 service existent by Covalent Bonds 2021-06-03
Celonis–SEVERAL: investment, 202106 financing round Series D $1b co-led by Durable Capital Partners + T Rowe Price 2021-06-02
Danaher–Celonis: management execution software, 202106 supply existent customer Danaher Corp 2021-06-02
GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva 2021-06-02
Univ Belfast–Agilent: grant, 202106– Thought Leader Award to Prof Chris Elliott at QUB IGFS for food safety analysis 2021-06-01
Univ Belfast–Agilent: LC system, 202106 supply 1290 Infinity II LC System as part of Thought Leader Award grant to QUB IGFS 2021-06-01
Univ Belfast–Agilent: mass spectrometer, 202106 supply 6546 LC-Q/TOF instrument as part of Thought Leader Award grant to QUB IGFS 2021-06-01
Univ Belfast–Agilent: mass spectrometer, 202106 supply 7850 ICP-MS instrument as part of Thought Leader Award grant to QUB IGFS 2021-06-01
Immunodiagnostic Systems–PerkinElmer: investment, 202105– recommended all cash offer £110m by PerkinElmer ANNOUNCED 2021-05-17
Nexcelom Bioscience–PerkinElmer: investment, 202105– acquisition $260m in cash from founders + Ampersand Capital Partners 2021-05-12
Danaher–Waters: LC systems, 202105– collab co-marketing Sciex offers MS systems interoperable with UPLC systems from Waters 2021-05-11
Agendia–Inivata: cancer test, 202104– co-excl distribution rights €na for RaDaR liquid biopsy assay for breast cancer in North America + Europe 2021-04-28
Siemens–Biognosys: MS-based biomarker discovery, 202104– strategic agreem marker discovery using HRM-MS for Dx assay development with S Healthineers 2021-04-13
Swift Biosciences–Danaher: investment, 202103 acquisition €na of Swift Biosciences by Integrated DNA Technologies 2021-03-11
Cognate BioServices–Charles River: investment, 202102–202103 acquisition $875m in cash by Charles River 2021-02-17
Thermo Fisher–Sidis: cell sorting technology, 202102 acquisition cell sorting assets incl Bigfoot Spectral Cell Sorter + 40 employees from Propel Labs 2021-02-17
Inivata–Farallon Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Farallon Capital 2021-02-04
Inivata–IP Group: investment, 202102 financing round Series C 2nd closing totalling $35m incl existing + co-investor IP Group 2021-02-04
Inivata–Janus Henderson: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Janus Henderson Investors 2021-02-04
Inivata–SEVERAL: investment, 202102 financing round Series C 2nd closing $35m led by Soleus Capital bringing total Series C to $60m 2021-02-04
Inivata–Soleus Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + lead investor Soleus Capital 2021-02-04
Tecan–UgenTec: laboratory automation, 202102– collab product integration of Tecan workstations with FastFinder qPCR-s/w for sale in dx markets 2021-02-04
Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD 2021-01-28
Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test 2021-01-28
Mobilion–Protein Metrics: mass spectrometry software, 202101– collab integration of Byos software suit with Mobilion HRIM MS system 2021-01-26
i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF 2021-01-25
i3 Membrane–OTHER: investment, 202101 financing round totalling 7-figure € sum incl three private investors 2021-01-25
i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors 2021-01-25
Intabio–Danaher: investment, 202101 acquisition $na of Intabio Inc by Sciex 2021-01-21
Numares–Bruker: NMR spectroscopy, 202102– collab developm + product integration Axinon platform for metabolomics-based NMR-CDx 2021-01-21
Mesa Biotech–Thermo Fisher: investment, 202101– acquisition $450m cash upfront + $100m cash milestones of Mesa Biotech Inc by Thermo Fisher 2021-01-19
Novasep–Thermo Fisher: investment, 202101 acquisition €725m in cash of viral vector manufacturing business Henogen SA in Belgium by Thermo Fisher 2021-01-15
Labforward–2mag: investment, 202101 financing round Series B totalling >€5m incl new + co-investor 2mag 2021-01-11
Labforward–Peppermint: investment, 202101 financing round Series B totalling >€5m incl existing + co-investor Peppermint VenturePartners 2021-01-11
Labforward–SEVERAL: investment, 202101 financing round Series B >€5m led by Tecan + incl 2mag + Peppermint VenturePartners 2021-01-11
Labforward–Tecan: investment, 202101 financing round Series B totalling >€5m incl €4m from new + lead investor Tecan resulting in 10% stake 2021-01-11
IsoPlexis–SEVERAL: credit, 202101– credit facility $50m 2021-01-07
IsoPlexis–SEVERAL: investment, 202101 financing round Series D $85m led by new investor Perceptive Advisors 2021-01-07
Oxford Immunotec–PerkinElmer: investment, 202101– acquisition $591m with $22/share in cash ANNOUNCED 2021-01-07
Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp 2021-01-06
Adeptrix–SEVERAL: investment, 202101 financing round Series A closed with new + minority investor Bruker Corp 2021-01-06
Distributed Bio–Charles River: investment, 202012 acquisition $83m upfront cash + $21m milestones 2020-12-31
Phitonex–Thermo Fisher: investment, 202012 acquisition fo Phitonex by Thermo Fisher Scientific 2020-12-31
SomaLogic–Amgen: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Amgen 2020-12-22
SomaLogic–Boston Millennia Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Boston Millenia Partners 2020-12-22
SomaLogic–Intermountain Ventures: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Intermountain Ventures 2020-12-22
SomaLogic–Janus Henderson: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Janus Henderson Investors 2020-12-22
SomaLogic–Logos Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Logos Capital 2020-12-22
SomaLogic–Millenium Management: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Millennium Management 2020-12-22
SomaLogic–NEC: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl NEC Solution Innovators Ltd 2020-12-22
SomaLogic–Novartis: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Novartis 2020-12-22
SomaLogic–Redmile Group: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Redmile Group 2020-12-22
SomaLogic–Revelation Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Revelation Partners 2020-12-22
SomaLogic–SEVERAL: investment, 202012 financing round Series A 2nd closing additional $81m bringing total Series A to $204m or $214m 2020-12-22
SomaLogic–Ziff Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Ziff Capital Healthcare Ventures 2020-12-22
908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market 2020-12-18
Kyungpook National Univ–Waters: mass spectrometer, 202012 supply first Select Series Cyclic IMS system in South Korea to S Kim 2020-12-08
Waters–Kyungpook National Univ: mass spectrometry, 202012– collab research expansion with S Kim using Cyclic IMS system for crude oil analysis 2020-12-08
Newomics–SEVERAL: investment, 202012 financing round Series B $7.9m led by MSA Capital 2020-12-01
Slack Technologies–Salesforce: investment, 202012– acquisition $27.7b in cash + shares of Slack by Salesforce ANNOUNCED 2020-12-01
SomaLogic–SEVERAL: investment, 202011 financing round Series A initial closing $121m led by Casdin Capital 2020-11-25
Emphysys–Paramit: investment, 202011 acquisition of Emphysis Inc by Paramit Corp 2020-11-24
Univ Pennsylvania–Agilent: grant, 202011– Thought Leader Award to Carl H June + M Milone at School of Medicine for cancer cell therapy 2020-11-17
m2p-labs–Danaher: investment, 202011 acquisition of m2p-biolabs by Beckman Coulter Life Sciences 2020-11-12
Eurofins–Waters: mass spectrometer, 202011 supply existent Radian ASAP System beta customer Eurofins Forenscis Teddington 2020-11-02
Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m) 2020-11-02
BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED 2020-10-02
Integrated Proteomics Applications–Bruker: investment, 202009 acquisition €na of assets by Bruker 2020-09-30
Prolytic–Kymos: investment, 202009 strategic merger of Polytic GmbH + Kymos SL 2020-09-28
Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp 2020-09-11
Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich 2020-09-01
Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system 2020-08-24
Mobilion–SEVERAL: investment, 202008 financing round Series B $35m led by aMoon + incl Agilent + IP Group + Hostplus + Cultivation Capital 2020-08-17
Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab 2020-08-07
DNA Script–SEVERAL: investment, 202007 financing round Series B extension $50m led by Casdin Capital 2020-07-29
Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery 2020-07-23
Resolution Spectra Systems–Merck (DE): investment, 202007 acquisition €na of Resolution Spectra Systems by Merck 2020-07-01
Waters–Heidrick & Struggles: recruitment services, 202007 supply service placement of Udit Batra as CEO of Waters 2020-07-01
Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC 2020-06-18
Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC 2020-06-18
Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 2020-04-28
1 2 3 4 5 6 7 8  next pagenext page



Advertisement

Picture [iito] Made Without Love 650x80px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com


Advertisement

Picture [iito] No Content Marketing 650x80px

» top